Truist Securities Maintains Buy on AdaptHealth, Lowers Price Target to $9
ADAPTHEALTH CORP
ADAPTHEALTH CORP AHCO | 0.00 |
Truist Securities analyst David Macdonald maintains AdaptHealth (NASDAQ:
AHCO) with a Buy and lowers the price target from $14 to $9.
